StonvexLoading…
StonvexStonvexStonvexCore line items from LZB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-26 | Annual 2024 2024-04-27 | Annual 2023 2023-04-29 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $2.11B | $2.05B | $2.35B | $2.36B |
Operating Income | $135.84M | $150.80M | $211.44M | $206.76M |
Net Income | $99.56M | $122.63M | $150.66M | $150.02M |
EPS (Diluted) | $2.35 | $2.83 | $3.48 | $3.39 |
Total Assets | $1.92B | $1.91B | $1.87B | $1.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $328.45M | $341.10M | $343.37M | $245.59M |
Free Cash Flow OCF − CapEx | $112.99M | $104.58M | $136.35M | $2.42M |
Shares Outstanding | 41.16M | 42.44M | 43.32M | 43.09M |